2023-2029 Global Peripheral Vasodilator Drugs Industry Research & Trends Analysis Report
- Category: Healthcare
- Published Date: Apr 2023
- Publisher: YH Research
- Pages: 144
According to Intelligence Market Report, the global market for Peripheral Vasodilator Drugs should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
China Peripheral Vasodilator Drugs market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
The United States Peripheral Vasodilator Drugs market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
In terms of type, Calcium Channel Blockers segment holds a share about % in 2022 and will reach % in 2029; while in terms of application, Hospital has a share approximately % in 2022 and will grow at a CAGR % during 2023 and 2029.
The global key manufacturers of Peripheral Vasodilator Drugs include Pfizer, Inc., Novartis AG, GSK plc, AstraZeneca, Merck & Co., Inc., Sanofi, Bayer AG, Abbott Laboratories and Bristol-Myers Squibb Company, etc. In 2022, the global top five players hold a share approximately % in terms of revenue.
Peripheral vasodilator drugs are a class of medications used to treat conditions related to the constriction of blood vessels in the peripheral tissues of the body. These drugs work by relaxing the smooth muscles in the walls of blood vessels.
This report aims to provide a comprehensive study of the global market for Peripheral Vasodilator Drugs. Report Highlights:
(1) Global Peripheral Vasodilator Drugs market size (sales volume & revenue), history data from 2018-2022 and forecast data from 2023 to 2029.
(2) Global Peripheral Vasodilator Drugs market competitive situation, sales, revenue, price and market share, from 2018 to 2022.
(3) China Peripheral Vasodilator Drugs market competitive situation, sales, revenue, price and market share, from 2018 to 2022.
(4) Global Peripheral Vasodilator Drugs segment by region (or country), key regions cover the United States, Europe, Japan, South Korea, Southeast Asia and India, etc.
(5) Global Peripheral Vasodilator Drugs segment by type and by application and regional segment by type and by application.
(6) Global major production regions of Peripheral Vasodilator Drugs, capacity, production and trends.
(7) Peripheral Vasodilator Drugs industry supply chain, upstream, midstream and downstream analysis.
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Market segment by type, covers
Calcium Channel Blockers
Alpha-adrenergic Blockers
Potassium Channel Activators
Others
Market segment by application, can be divided into
Hospital
Retail Pharmacies
Others
Market segment by players, this report covers
Pfizer, Inc.
Novartis AG
GSK plc
AstraZeneca
Merck & Co., Inc.
Sanofi
Bayer AG
Abbott Laboratories
Bristol-Myers Squibb Company
Boehringer Ingelheim International GmbH
Teva Pharmaceutical Industries Ltd.
Viatris, Inc.
Sun Pharmaceutical Industries Ltd.
Lupin
China Peripheral Vasodilator Drugs market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
The United States Peripheral Vasodilator Drugs market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
In terms of type, Calcium Channel Blockers segment holds a share about % in 2022 and will reach % in 2029; while in terms of application, Hospital has a share approximately % in 2022 and will grow at a CAGR % during 2023 and 2029.
The global key manufacturers of Peripheral Vasodilator Drugs include Pfizer, Inc., Novartis AG, GSK plc, AstraZeneca, Merck & Co., Inc., Sanofi, Bayer AG, Abbott Laboratories and Bristol-Myers Squibb Company, etc. In 2022, the global top five players hold a share approximately % in terms of revenue.
Peripheral vasodilator drugs are a class of medications used to treat conditions related to the constriction of blood vessels in the peripheral tissues of the body. These drugs work by relaxing the smooth muscles in the walls of blood vessels.
This report aims to provide a comprehensive study of the global market for Peripheral Vasodilator Drugs. Report Highlights:
(1) Global Peripheral Vasodilator Drugs market size (sales volume & revenue), history data from 2018-2022 and forecast data from 2023 to 2029.
(2) Global Peripheral Vasodilator Drugs market competitive situation, sales, revenue, price and market share, from 2018 to 2022.
(3) China Peripheral Vasodilator Drugs market competitive situation, sales, revenue, price and market share, from 2018 to 2022.
(4) Global Peripheral Vasodilator Drugs segment by region (or country), key regions cover the United States, Europe, Japan, South Korea, Southeast Asia and India, etc.
(5) Global Peripheral Vasodilator Drugs segment by type and by application and regional segment by type and by application.
(6) Global major production regions of Peripheral Vasodilator Drugs, capacity, production and trends.
(7) Peripheral Vasodilator Drugs industry supply chain, upstream, midstream and downstream analysis.
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Market segment by type, covers
Calcium Channel Blockers
Alpha-adrenergic Blockers
Potassium Channel Activators
Others
Market segment by application, can be divided into
Hospital
Retail Pharmacies
Others
Market segment by players, this report covers
Pfizer, Inc.
Novartis AG
GSK plc
AstraZeneca
Merck & Co., Inc.
Sanofi
Bayer AG
Abbott Laboratories
Bristol-Myers Squibb Company
Boehringer Ingelheim International GmbH
Teva Pharmaceutical Industries Ltd.
Viatris, Inc.
Sun Pharmaceutical Industries Ltd.
Lupin
1 Market Overview
1.1 Peripheral Vasodilator Drugs Definition
1.2 Global Peripheral Vasodilator Drugs Market Size and Forecast
1.2.1 By Revenue, Global Peripheral Vasodilator Drugs Market Size, 2018-2029
1.2.2 By Sales Volume, Global Peripheral Vasodilator Drugs Market Size, 2018-2029
1.2.3 Global Peripheral Vasodilator Drugs Price Trend, 2018-2029
1.3 China Peripheral Vasodilator Drugs Market Size and Forecast
1.3.1 By Revenue, China Peripheral Vasodilator Drugs Market Size, 2018-2029
1.3.2 By Sales Volume, China Peripheral Vasodilator Drugs Market Size, 2018-2029
1.3.3 China Peripheral Vasodilator Drugs Price Trend, 2018-2029
1.4 China Percentage in Global Market
1.4.1 By Revenue, China Peripheral Vasodilator Drugs Share in Global Market, 2018-2029
1.4.2 By Sales Volume, China Peripheral Vasodilator Drugs Share in Global Market, 2018-2029
1.4.3 Peripheral Vasodilator Drugs Market Size: China VS Global, 2018-2029
1.5 Peripheral Vasodilator Drugs Market Dynamics
1.5.1 Peripheral Vasodilator Drugs Market Drivers
1.5.2 Peripheral Vasodilator Drugs Market Restraints
1.5.3 Peripheral Vasodilator Drugs Industry Trends
1.5.4 Peripheral Vasodilator Drugs Industry Policy
2 Global Competitive Landscape by Company
2.1 Global Peripheral Vasodilator Drugs Revenue by Company, 2018-2023
2.2 Global Peripheral Vasodilator Drugs Sales Volume by Company, 2018-2023
2.3 Global Peripheral Vasodilator Drugs Price by Company, 2018-2023
2.4 Global Peripheral Vasodilator Drugs Participants, Market Position (Tier 1, Tier 2 and Tier 3)
2.5 Global Peripheral Vasodilator Drugs Concentration Ratio
2.6 Global Peripheral Vasodilator Drugs Mergers & Acquisitions, Expansion Plans
2.7 Global Peripheral Vasodilator Drugs Manufacturers Product Type
3 China Competitive Landscape by Company
3.1 China Peripheral Vasodilator Drugs Revenue by Company, 2018-2023
3.2 China Peripheral Vasodilator Drugs Sales Volume by Company, 2018-2023
3.3 China Peripheral Vasodilator Drugs Peripheral Vasodilator Drugs Participants, Market Position (Tier 1, Tier 2 and Tier 3)
3.4 China Peripheral Vasodilator Drugs Market, Sales Percentage of Local Players VS Foreign Players (2018-2023)
3.5 Chinese Local Players, Peripheral Vasodilator Drugs Domestic VS Export
3.6 China Market, Peripheral Vasodilator Drugs Import & Export
3.6.1 China Market, Peripheral Vasodilator Drugs Import & Export, 2018-2029
3.6.2 China Peripheral Vasodilator Drugs Import & Export Trends
3.6.3 Main Sources of China Peripheral Vasodilator Drugs Import
3.6.4 Export Destination of China Peripheral Vasodilator Drugs
4 Peripheral Vasodilator Drugs Production by Region
4.1 Global Peripheral Vasodilator Drugs Capacity, Production and Capacity Utilization, 2018-2029
4.2 Global Geographic Distribution of Peripheral Vasodilator Drugs Manufacturers
4.3 Global Major Manufacturers, Peripheral Vasodilator Drugs Capacity Expansion and Future Plans
4.4 Global Peripheral Vasodilator Drugs Capacity by Region
4.5 Global Peripheral Vasodilator Drugs Production by Region
4.5.1 Global Peripheral Vasodilator Drugs Production & Forecast by Region, 2018 VS 2022 VS 2029
4.5.2 Global Peripheral Vasodilator Drugs Production by Region, 2018-2023
4.5.3 Global Peripheral Vasodilator Drugs Production Market Share & Forecast by Region, 2018-2029
5 Industry Chain Analysis
5.1 Peripheral Vasodilator Drugs Industry Chain
5.2 Peripheral Vasodilator Drugs Upstream Analysis
5.2.1 Peripheral Vasodilator Drugs Core Raw Materials
5.2.2 Main Manufacturers of Peripheral Vasodilator Drugs Core Raw Materials
5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 Peripheral Vasodilator Drugs Production Mode
5.6 Peripheral Vasodilator Drugs Procurement Model
5.7 Peripheral Vasodilator Drugs Industry Sales Model and Sales Channels
5.7.1 Peripheral Vasodilator Drugs Sales Model
5.7.2 Peripheral Vasodilator Drugs Typical Distributors
6 Sights by Type
6.1 Peripheral Vasodilator Drugs Classification
6.1.1 Calcium Channel Blockers
6.1.2 Alpha-adrenergic Blockers
6.1.3 Potassium Channel Activators
6.1.4 Others
6.2 By Type, Global Peripheral Vasodilator Drugs Market Size & CAGR, 2018 VS 2022 VS 2029
6.3 By Type, Global Peripheral Vasodilator Drugs Revenue, 2018-2029
6.4 By Type, Global Peripheral Vasodilator Drugs Sales Volume, 2018-2029
6.5 By Type, Global Peripheral Vasodilator Drugs Price, 2018-2029
7 Sights by Application
7.1 Peripheral Vasodilator Drugs Segment by Application
7.1.1 Hospital
7.1.2 Retail Pharmacies
7.1.3 Others
7.2 By Application, Global Peripheral Vasodilator Drugs Market Size & CAGR, 2018 VS 2022 VS 2029
7.3 By Application, Global Peripheral Vasodilator Drugs Revenue, 2018-2029
7.4 By Application, Global Peripheral Vasodilator Drugs Sales Volume, 2018-2029
7.5 By Application, Global Peripheral Vasodilator Drugs Price, 2018-2029
8 Sales Sights by Region
8.1 By Region, Global Peripheral Vasodilator Drugs Market Size, 2018 VS 2022 VS 2029
8.2 By Region, Global Peripheral Vasodilator Drugs Revenue, 2018-2029
8.3 By Region, Global Peripheral Vasodilator Drugs Sales Volume, 2018-2029
8.4 North America
8.4.1 North America Peripheral Vasodilator Drugs Market Size & Forecasts, 2018-2029
8.4.2 By Country, North America Peripheral Vasodilator Drugs Market Size Market Share
8.5 Europe
8.5.1 Europe Peripheral Vasodilator Drugs Market Size & Forecasts, 2018-2029
8.5.2 By Country, Europe Peripheral Vasodilator Drugs Market Size Market Share
8.6 Asia Pacific
8.6.1 Asia Pacific Peripheral Vasodilator Drugs Market Size & Forecasts, 2018-2029
8.6.2 By Country/Region, Asia Pacific Peripheral Vasodilator Drugs Market Size Market Share
8.7 South America
8.7.1 South America Peripheral Vasodilator Drugs Market Size & Forecasts, 2018-2029
8.7.2 By Country, South America Peripheral Vasodilator Drugs Market Size Market Share
8.8 Middle East & Africa
9 Sales Sights by Country Level
9.1 By Country, Global Peripheral Vasodilator Drugs Market Size & CAGR，2018 VS 2022 VS 2029
9.2 By Country, Global Peripheral Vasodilator Drugs Revenue, 2018-2029
9.3 By Country, Global Peripheral Vasodilator Drugs Sales Volume, 2018-2029
9.4 U.S.
9.4.1 U.S. Peripheral Vasodilator Drugs Market Size, 2018-2029
9.4.2 By Company, U.S. Peripheral Vasodilator Drugs Sales Volume Market Share, 2022
9.4.3 By Type, U.S. Peripheral Vasodilator Drugs Market Size, Share, 2022 VS 2029
9.4.4 By Application, U.S. Peripheral Vasodilator Drugs Market Size, Share, 2022 VS 2029
9.5 Europe
9.5.1 Europe Peripheral Vasodilator Drugs Market Size, 2018-2029
9.5.2 By Company, Europe Peripheral Vasodilator Drugs Sales Volume Market Share, 2022
9.5.3 By Type, Europe Peripheral Vasodilator Drugs Market Size, Share, 2022 VS 2029
9.5.4 By Application, Europe Peripheral Vasodilator Drugs Market Size, Share, 2022 VS 2029
9.6 China
9.6.1 China Peripheral Vasodilator Drugs Market Size, 2018-2029
9.6.2 By Company, China Peripheral Vasodilator Drugs Sales Volume Market Share, 2022
9.6.3 By Type, China Peripheral Vasodilator Drugs Market Size, Share, 2022 VS 2029
9.6.4 By Application, China Peripheral Vasodilator Drugs Market Size, Share, 2022 VS 2029
9.7 Japan
9.7.1 Japan Peripheral Vasodilator Drugs Market Size, 2018-2029
9.7.2 By Company, Japan Peripheral Vasodilator Drugs Sales Volume Market Share, 2022
9.7.3 By Type, Japan Peripheral Vasodilator Drugs Market Size, Share, 2022 VS 2029
9.7.4 By Application, Japan Peripheral Vasodilator Drugs Market Size, Share, 2022 VS 2029
9.8 South Korea
9.8.1 South Korea Peripheral Vasodilator Drugs Market Size, 2018-2029
9.8.2 By Company, South Korea Peripheral Vasodilator Drugs Sales Volume Market Share, 2022
9.8.3 By Type, South Korea Peripheral Vasodilator Drugs Market Size, Share, 2022 VS 2029
9.8.4 By Application, South Korea Peripheral Vasodilator Drugs Market Size, Share, 2022 VS 2029
9.9 Southeast Asia
9.9.1 Southeast Asia Peripheral Vasodilator Drugs Market Size, 2018-2029
9.9.2 By Company, Southeast Asia Peripheral Vasodilator Drugs Sales Volume Market Share, 2022
9.9.3 By Type, Southeast Asia Peripheral Vasodilator Drugs Market Size, Share, 2022 VS 2029
9.9.4 By Application, Southeast Asia Peripheral Vasodilator Drugs Market Size, Share, 2022 VS 2029
9.10 India
9.10.1 India Peripheral Vasodilator Drugs Market Size, 2018-2029
9.10.2 By Company, India Peripheral Vasodilator Drugs Sales Volume Market Share, 2022
9.10.3 By Type, India Peripheral Vasodilator Drugs Market Size, Share, 2022 VS 2029
9.10.4 By Application, India Peripheral Vasodilator Drugs Market Size, Share, 2022 VS 2029
9.11 Middle East & Asia
9.11.1 Middle East & Asia Peripheral Vasodilator Drugs Market Size, 2018-2029
9.11.2 By Company, Middle East & Asia Peripheral Vasodilator Drugs Sales Volume Market Share, 2022
9.11.3 By Type, Middle East & Asia Peripheral Vasodilator Drugs Market Size, Share, 2022 VS 2029
9.11.4 By Application, Middle East & Asia Peripheral Vasodilator Drugs Market Size, Share, 2022 VS 2029
10 Manufacturers Profile
10.1 Pfizer, Inc.
10.1.1 Pfizer, Inc. Company Information, Head Office, Market Area and Industry Position
10.1.2 Pfizer, Inc. Peripheral Vasodilator Drugs Models, Specifications and Application
10.1.3 Pfizer, Inc. Peripheral Vasodilator Drugs Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.1.4 Pfizer, Inc. Company Profile and Main Business
10.1.5 Pfizer, Inc. Recent Developments
10.2 Novartis AG
10.2.1 Novartis AG Company Information, Head Office, Market Area and Industry Position
10.2.2 Novartis AG Peripheral Vasodilator Drugs Models, Specifications and Application
10.2.3 Novartis AG Peripheral Vasodilator Drugs Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.2.4 Novartis AG Company Profile and Main Business
10.2.5 Novartis AG Recent Developments
10.3 GSK plc
10.3.1 GSK plc Company Information, Head Office, Market Area and Industry Position
10.3.2 GSK plc Peripheral Vasodilator Drugs Models, Specifications and Application
10.3.3 GSK plc Peripheral Vasodilator Drugs Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.3.4 GSK plc Company Profile and Main Business
10.3.5 GSK plc Recent Developments
10.4 AstraZeneca
10.4.1 AstraZeneca Company Information, Head Office, Market Area and Industry Position
10.4.2 AstraZeneca Peripheral Vasodilator Drugs Models, Specifications and Application
10.4.3 AstraZeneca Peripheral Vasodilator Drugs Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.4.4 AstraZeneca Company Profile and Main Business
10.4.5 AstraZeneca Recent Developments
10.5 Merck & Co., Inc.
10.5.1 Merck & Co., Inc. Company Information, Head Office, Market Area and Industry Position
10.5.2 Merck & Co., Inc. Peripheral Vasodilator Drugs Models, Specifications and Application
10.5.3 Merck & Co., Inc. Peripheral Vasodilator Drugs Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.5.4 Merck & Co., Inc. Company Profile and Main Business
10.5.5 Merck & Co., Inc. Recent Developments
10.6 Sanofi
10.6.1 Sanofi Company Information, Head Office, Market Area and Industry Position
10.6.2 Sanofi Peripheral Vasodilator Drugs Models, Specifications and Application
10.6.3 Sanofi Peripheral Vasodilator Drugs Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.6.4 Sanofi Company Profile and Main Business
10.6.5 Sanofi Recent Developments
10.7 Bayer AG
10.7.1 Bayer AG Company Information, Head Office, Market Area and Industry Position
10.7.2 Bayer AG Peripheral Vasodilator Drugs Models, Specifications and Application
10.7.3 Bayer AG Peripheral Vasodilator Drugs Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.7.4 Bayer AG Company Profile and Main Business
10.7.5 Bayer AG Recent Developments
10.8 Abbott Laboratories
10.8.1 Abbott Laboratories Company Information, Head Office, Market Area and Industry Position
10.8.2 Abbott Laboratories Peripheral Vasodilator Drugs Models, Specifications and Application
10.8.3 Abbott Laboratories Peripheral Vasodilator Drugs Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.8.4 Abbott Laboratories Company Profile and Main Business
10.8.5 Abbott Laboratories Recent Developments
10.9 Bristol-Myers Squibb Company
10.9.1 Bristol-Myers Squibb Company Company Information, Head Office, Market Area and Industry Position
10.9.2 Bristol-Myers Squibb Company Peripheral Vasodilator Drugs Models, Specifications and Application
10.9.3 Bristol-Myers Squibb Company Peripheral Vasodilator Drugs Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.9.4 Bristol-Myers Squibb Company Company Profile and Main Business
10.9.5 Bristol-Myers Squibb Company Recent Developments
10.10 Boehringer Ingelheim International GmbH
10.10.1 Boehringer Ingelheim International GmbH Company Information, Head Office, Market Area and Industry Position
10.10.2 Boehringer Ingelheim International GmbH Peripheral Vasodilator Drugs Models, Specifications and Application
10.10.3 Boehringer Ingelheim International GmbH Peripheral Vasodilator Drugs Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.10.4 Boehringer Ingelheim International GmbH Company Profile and Main Business
10.10.5 Boehringer Ingelheim International GmbH Recent Developments
10.11 Teva Pharmaceutical Industries Ltd.
10.11.1 Teva Pharmaceutical Industries Ltd. Company Information, Head Office, Market Area and Industry Position
10.11.2 Teva Pharmaceutical Industries Ltd. Peripheral Vasodilator Drugs Models, Specifications and Application
10.11.3 Teva Pharmaceutical Industries Ltd. Peripheral Vasodilator Drugs Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.11.4 Teva Pharmaceutical Industries Ltd. Company Profile and Main Business
10.11.5 Teva Pharmaceutical Industries Ltd. Recent Developments
10.12 Viatris, Inc.
10.12.1 Viatris, Inc. Company Information, Head Office, Market Area and Industry Position
10.12.2 Viatris, Inc. Peripheral Vasodilator Drugs Models, Specifications and Application
10.12.3 Viatris, Inc. Peripheral Vasodilator Drugs Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.12.4 Viatris, Inc. Company Profile and Main Business
10.12.5 Viatris, Inc. Recent Developments
10.13 Sun Pharmaceutical Industries Ltd.
10.13.1 Sun Pharmaceutical Industries Ltd. Company Information, Head Office, Market Area and Industry Position
10.13.2 Sun Pharmaceutical Industries Ltd. Peripheral Vasodilator Drugs Models, Specifications and Application
10.13.3 Sun Pharmaceutical Industries Ltd. Peripheral Vasodilator Drugs Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.13.4 Sun Pharmaceutical Industries Ltd. Company Profile and Main Business
10.13.5 Sun Pharmaceutical Industries Ltd. Recent Developments
10.14 Lupin
10.14.1 Lupin Company Information, Head Office, Market Area and Industry Position
10.14.2 Lupin Peripheral Vasodilator Drugs Models, Specifications and Application
10.14.3 Lupin Peripheral Vasodilator Drugs Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.14.4 Lupin Company Profile and Main Business
10.14.5 Lupin Recent Developments
11 Conclusion
12 Appendix
12.1 Research Methodology
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Market Estimation Model
12.4 Disclaimer
1.1 Peripheral Vasodilator Drugs Definition
1.2 Global Peripheral Vasodilator Drugs Market Size and Forecast
1.2.1 By Revenue, Global Peripheral Vasodilator Drugs Market Size, 2018-2029
1.2.2 By Sales Volume, Global Peripheral Vasodilator Drugs Market Size, 2018-2029
1.2.3 Global Peripheral Vasodilator Drugs Price Trend, 2018-2029
1.3 China Peripheral Vasodilator Drugs Market Size and Forecast
1.3.1 By Revenue, China Peripheral Vasodilator Drugs Market Size, 2018-2029
1.3.2 By Sales Volume, China Peripheral Vasodilator Drugs Market Size, 2018-2029
1.3.3 China Peripheral Vasodilator Drugs Price Trend, 2018-2029
1.4 China Percentage in Global Market
1.4.1 By Revenue, China Peripheral Vasodilator Drugs Share in Global Market, 2018-2029
1.4.2 By Sales Volume, China Peripheral Vasodilator Drugs Share in Global Market, 2018-2029
1.4.3 Peripheral Vasodilator Drugs Market Size: China VS Global, 2018-2029
1.5 Peripheral Vasodilator Drugs Market Dynamics
1.5.1 Peripheral Vasodilator Drugs Market Drivers
1.5.2 Peripheral Vasodilator Drugs Market Restraints
1.5.3 Peripheral Vasodilator Drugs Industry Trends
1.5.4 Peripheral Vasodilator Drugs Industry Policy
2 Global Competitive Landscape by Company
2.1 Global Peripheral Vasodilator Drugs Revenue by Company, 2018-2023
2.2 Global Peripheral Vasodilator Drugs Sales Volume by Company, 2018-2023
2.3 Global Peripheral Vasodilator Drugs Price by Company, 2018-2023
2.4 Global Peripheral Vasodilator Drugs Participants, Market Position (Tier 1, Tier 2 and Tier 3)
2.5 Global Peripheral Vasodilator Drugs Concentration Ratio
2.6 Global Peripheral Vasodilator Drugs Mergers & Acquisitions, Expansion Plans
2.7 Global Peripheral Vasodilator Drugs Manufacturers Product Type
3 China Competitive Landscape by Company
3.1 China Peripheral Vasodilator Drugs Revenue by Company, 2018-2023
3.2 China Peripheral Vasodilator Drugs Sales Volume by Company, 2018-2023
3.3 China Peripheral Vasodilator Drugs Peripheral Vasodilator Drugs Participants, Market Position (Tier 1, Tier 2 and Tier 3)
3.4 China Peripheral Vasodilator Drugs Market, Sales Percentage of Local Players VS Foreign Players (2018-2023)
3.5 Chinese Local Players, Peripheral Vasodilator Drugs Domestic VS Export
3.6 China Market, Peripheral Vasodilator Drugs Import & Export
3.6.1 China Market, Peripheral Vasodilator Drugs Import & Export, 2018-2029
3.6.2 China Peripheral Vasodilator Drugs Import & Export Trends
3.6.3 Main Sources of China Peripheral Vasodilator Drugs Import
3.6.4 Export Destination of China Peripheral Vasodilator Drugs
4 Peripheral Vasodilator Drugs Production by Region
4.1 Global Peripheral Vasodilator Drugs Capacity, Production and Capacity Utilization, 2018-2029
4.2 Global Geographic Distribution of Peripheral Vasodilator Drugs Manufacturers
4.3 Global Major Manufacturers, Peripheral Vasodilator Drugs Capacity Expansion and Future Plans
4.4 Global Peripheral Vasodilator Drugs Capacity by Region
4.5 Global Peripheral Vasodilator Drugs Production by Region
4.5.1 Global Peripheral Vasodilator Drugs Production & Forecast by Region, 2018 VS 2022 VS 2029
4.5.2 Global Peripheral Vasodilator Drugs Production by Region, 2018-2023
4.5.3 Global Peripheral Vasodilator Drugs Production Market Share & Forecast by Region, 2018-2029
5 Industry Chain Analysis
5.1 Peripheral Vasodilator Drugs Industry Chain
5.2 Peripheral Vasodilator Drugs Upstream Analysis
5.2.1 Peripheral Vasodilator Drugs Core Raw Materials
5.2.2 Main Manufacturers of Peripheral Vasodilator Drugs Core Raw Materials
5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 Peripheral Vasodilator Drugs Production Mode
5.6 Peripheral Vasodilator Drugs Procurement Model
5.7 Peripheral Vasodilator Drugs Industry Sales Model and Sales Channels
5.7.1 Peripheral Vasodilator Drugs Sales Model
5.7.2 Peripheral Vasodilator Drugs Typical Distributors
6 Sights by Type
6.1 Peripheral Vasodilator Drugs Classification
6.1.1 Calcium Channel Blockers
6.1.2 Alpha-adrenergic Blockers
6.1.3 Potassium Channel Activators
6.1.4 Others
6.2 By Type, Global Peripheral Vasodilator Drugs Market Size & CAGR, 2018 VS 2022 VS 2029
6.3 By Type, Global Peripheral Vasodilator Drugs Revenue, 2018-2029
6.4 By Type, Global Peripheral Vasodilator Drugs Sales Volume, 2018-2029
6.5 By Type, Global Peripheral Vasodilator Drugs Price, 2018-2029
7 Sights by Application
7.1 Peripheral Vasodilator Drugs Segment by Application
7.1.1 Hospital
7.1.2 Retail Pharmacies
7.1.3 Others
7.2 By Application, Global Peripheral Vasodilator Drugs Market Size & CAGR, 2018 VS 2022 VS 2029
7.3 By Application, Global Peripheral Vasodilator Drugs Revenue, 2018-2029
7.4 By Application, Global Peripheral Vasodilator Drugs Sales Volume, 2018-2029
7.5 By Application, Global Peripheral Vasodilator Drugs Price, 2018-2029
8 Sales Sights by Region
8.1 By Region, Global Peripheral Vasodilator Drugs Market Size, 2018 VS 2022 VS 2029
8.2 By Region, Global Peripheral Vasodilator Drugs Revenue, 2018-2029
8.3 By Region, Global Peripheral Vasodilator Drugs Sales Volume, 2018-2029
8.4 North America
8.4.1 North America Peripheral Vasodilator Drugs Market Size & Forecasts, 2018-2029
8.4.2 By Country, North America Peripheral Vasodilator Drugs Market Size Market Share
8.5 Europe
8.5.1 Europe Peripheral Vasodilator Drugs Market Size & Forecasts, 2018-2029
8.5.2 By Country, Europe Peripheral Vasodilator Drugs Market Size Market Share
8.6 Asia Pacific
8.6.1 Asia Pacific Peripheral Vasodilator Drugs Market Size & Forecasts, 2018-2029
8.6.2 By Country/Region, Asia Pacific Peripheral Vasodilator Drugs Market Size Market Share
8.7 South America
8.7.1 South America Peripheral Vasodilator Drugs Market Size & Forecasts, 2018-2029
8.7.2 By Country, South America Peripheral Vasodilator Drugs Market Size Market Share
8.8 Middle East & Africa
9 Sales Sights by Country Level
9.1 By Country, Global Peripheral Vasodilator Drugs Market Size & CAGR，2018 VS 2022 VS 2029
9.2 By Country, Global Peripheral Vasodilator Drugs Revenue, 2018-2029
9.3 By Country, Global Peripheral Vasodilator Drugs Sales Volume, 2018-2029
9.4 U.S.
9.4.1 U.S. Peripheral Vasodilator Drugs Market Size, 2018-2029
9.4.2 By Company, U.S. Peripheral Vasodilator Drugs Sales Volume Market Share, 2022
9.4.3 By Type, U.S. Peripheral Vasodilator Drugs Market Size, Share, 2022 VS 2029
9.4.4 By Application, U.S. Peripheral Vasodilator Drugs Market Size, Share, 2022 VS 2029
9.5 Europe
9.5.1 Europe Peripheral Vasodilator Drugs Market Size, 2018-2029
9.5.2 By Company, Europe Peripheral Vasodilator Drugs Sales Volume Market Share, 2022
9.5.3 By Type, Europe Peripheral Vasodilator Drugs Market Size, Share, 2022 VS 2029
9.5.4 By Application, Europe Peripheral Vasodilator Drugs Market Size, Share, 2022 VS 2029
9.6 China
9.6.1 China Peripheral Vasodilator Drugs Market Size, 2018-2029
9.6.2 By Company, China Peripheral Vasodilator Drugs Sales Volume Market Share, 2022
9.6.3 By Type, China Peripheral Vasodilator Drugs Market Size, Share, 2022 VS 2029
9.6.4 By Application, China Peripheral Vasodilator Drugs Market Size, Share, 2022 VS 2029
9.7 Japan
9.7.1 Japan Peripheral Vasodilator Drugs Market Size, 2018-2029
9.7.2 By Company, Japan Peripheral Vasodilator Drugs Sales Volume Market Share, 2022
9.7.3 By Type, Japan Peripheral Vasodilator Drugs Market Size, Share, 2022 VS 2029
9.7.4 By Application, Japan Peripheral Vasodilator Drugs Market Size, Share, 2022 VS 2029
9.8 South Korea
9.8.1 South Korea Peripheral Vasodilator Drugs Market Size, 2018-2029
9.8.2 By Company, South Korea Peripheral Vasodilator Drugs Sales Volume Market Share, 2022
9.8.3 By Type, South Korea Peripheral Vasodilator Drugs Market Size, Share, 2022 VS 2029
9.8.4 By Application, South Korea Peripheral Vasodilator Drugs Market Size, Share, 2022 VS 2029
9.9 Southeast Asia
9.9.1 Southeast Asia Peripheral Vasodilator Drugs Market Size, 2018-2029
9.9.2 By Company, Southeast Asia Peripheral Vasodilator Drugs Sales Volume Market Share, 2022
9.9.3 By Type, Southeast Asia Peripheral Vasodilator Drugs Market Size, Share, 2022 VS 2029
9.9.4 By Application, Southeast Asia Peripheral Vasodilator Drugs Market Size, Share, 2022 VS 2029
9.10 India
9.10.1 India Peripheral Vasodilator Drugs Market Size, 2018-2029
9.10.2 By Company, India Peripheral Vasodilator Drugs Sales Volume Market Share, 2022
9.10.3 By Type, India Peripheral Vasodilator Drugs Market Size, Share, 2022 VS 2029
9.10.4 By Application, India Peripheral Vasodilator Drugs Market Size, Share, 2022 VS 2029
9.11 Middle East & Asia
9.11.1 Middle East & Asia Peripheral Vasodilator Drugs Market Size, 2018-2029
9.11.2 By Company, Middle East & Asia Peripheral Vasodilator Drugs Sales Volume Market Share, 2022
9.11.3 By Type, Middle East & Asia Peripheral Vasodilator Drugs Market Size, Share, 2022 VS 2029
9.11.4 By Application, Middle East & Asia Peripheral Vasodilator Drugs Market Size, Share, 2022 VS 2029
10 Manufacturers Profile
10.1 Pfizer, Inc.
10.1.1 Pfizer, Inc. Company Information, Head Office, Market Area and Industry Position
10.1.2 Pfizer, Inc. Peripheral Vasodilator Drugs Models, Specifications and Application
10.1.3 Pfizer, Inc. Peripheral Vasodilator Drugs Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.1.4 Pfizer, Inc. Company Profile and Main Business
10.1.5 Pfizer, Inc. Recent Developments
10.2 Novartis AG
10.2.1 Novartis AG Company Information, Head Office, Market Area and Industry Position
10.2.2 Novartis AG Peripheral Vasodilator Drugs Models, Specifications and Application
10.2.3 Novartis AG Peripheral Vasodilator Drugs Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.2.4 Novartis AG Company Profile and Main Business
10.2.5 Novartis AG Recent Developments
10.3 GSK plc
10.3.1 GSK plc Company Information, Head Office, Market Area and Industry Position
10.3.2 GSK plc Peripheral Vasodilator Drugs Models, Specifications and Application
10.3.3 GSK plc Peripheral Vasodilator Drugs Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.3.4 GSK plc Company Profile and Main Business
10.3.5 GSK plc Recent Developments
10.4 AstraZeneca
10.4.1 AstraZeneca Company Information, Head Office, Market Area and Industry Position
10.4.2 AstraZeneca Peripheral Vasodilator Drugs Models, Specifications and Application
10.4.3 AstraZeneca Peripheral Vasodilator Drugs Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.4.4 AstraZeneca Company Profile and Main Business
10.4.5 AstraZeneca Recent Developments
10.5 Merck & Co., Inc.
10.5.1 Merck & Co., Inc. Company Information, Head Office, Market Area and Industry Position
10.5.2 Merck & Co., Inc. Peripheral Vasodilator Drugs Models, Specifications and Application
10.5.3 Merck & Co., Inc. Peripheral Vasodilator Drugs Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.5.4 Merck & Co., Inc. Company Profile and Main Business
10.5.5 Merck & Co., Inc. Recent Developments
10.6 Sanofi
10.6.1 Sanofi Company Information, Head Office, Market Area and Industry Position
10.6.2 Sanofi Peripheral Vasodilator Drugs Models, Specifications and Application
10.6.3 Sanofi Peripheral Vasodilator Drugs Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.6.4 Sanofi Company Profile and Main Business
10.6.5 Sanofi Recent Developments
10.7 Bayer AG
10.7.1 Bayer AG Company Information, Head Office, Market Area and Industry Position
10.7.2 Bayer AG Peripheral Vasodilator Drugs Models, Specifications and Application
10.7.3 Bayer AG Peripheral Vasodilator Drugs Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.7.4 Bayer AG Company Profile and Main Business
10.7.5 Bayer AG Recent Developments
10.8 Abbott Laboratories
10.8.1 Abbott Laboratories Company Information, Head Office, Market Area and Industry Position
10.8.2 Abbott Laboratories Peripheral Vasodilator Drugs Models, Specifications and Application
10.8.3 Abbott Laboratories Peripheral Vasodilator Drugs Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.8.4 Abbott Laboratories Company Profile and Main Business
10.8.5 Abbott Laboratories Recent Developments
10.9 Bristol-Myers Squibb Company
10.9.1 Bristol-Myers Squibb Company Company Information, Head Office, Market Area and Industry Position
10.9.2 Bristol-Myers Squibb Company Peripheral Vasodilator Drugs Models, Specifications and Application
10.9.3 Bristol-Myers Squibb Company Peripheral Vasodilator Drugs Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.9.4 Bristol-Myers Squibb Company Company Profile and Main Business
10.9.5 Bristol-Myers Squibb Company Recent Developments
10.10 Boehringer Ingelheim International GmbH
10.10.1 Boehringer Ingelheim International GmbH Company Information, Head Office, Market Area and Industry Position
10.10.2 Boehringer Ingelheim International GmbH Peripheral Vasodilator Drugs Models, Specifications and Application
10.10.3 Boehringer Ingelheim International GmbH Peripheral Vasodilator Drugs Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.10.4 Boehringer Ingelheim International GmbH Company Profile and Main Business
10.10.5 Boehringer Ingelheim International GmbH Recent Developments
10.11 Teva Pharmaceutical Industries Ltd.
10.11.1 Teva Pharmaceutical Industries Ltd. Company Information, Head Office, Market Area and Industry Position
10.11.2 Teva Pharmaceutical Industries Ltd. Peripheral Vasodilator Drugs Models, Specifications and Application
10.11.3 Teva Pharmaceutical Industries Ltd. Peripheral Vasodilator Drugs Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.11.4 Teva Pharmaceutical Industries Ltd. Company Profile and Main Business
10.11.5 Teva Pharmaceutical Industries Ltd. Recent Developments
10.12 Viatris, Inc.
10.12.1 Viatris, Inc. Company Information, Head Office, Market Area and Industry Position
10.12.2 Viatris, Inc. Peripheral Vasodilator Drugs Models, Specifications and Application
10.12.3 Viatris, Inc. Peripheral Vasodilator Drugs Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.12.4 Viatris, Inc. Company Profile and Main Business
10.12.5 Viatris, Inc. Recent Developments
10.13 Sun Pharmaceutical Industries Ltd.
10.13.1 Sun Pharmaceutical Industries Ltd. Company Information, Head Office, Market Area and Industry Position
10.13.2 Sun Pharmaceutical Industries Ltd. Peripheral Vasodilator Drugs Models, Specifications and Application
10.13.3 Sun Pharmaceutical Industries Ltd. Peripheral Vasodilator Drugs Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.13.4 Sun Pharmaceutical Industries Ltd. Company Profile and Main Business
10.13.5 Sun Pharmaceutical Industries Ltd. Recent Developments
10.14 Lupin
10.14.1 Lupin Company Information, Head Office, Market Area and Industry Position
10.14.2 Lupin Peripheral Vasodilator Drugs Models, Specifications and Application
10.14.3 Lupin Peripheral Vasodilator Drugs Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.14.4 Lupin Company Profile and Main Business
10.14.5 Lupin Recent Developments
11 Conclusion
12 Appendix
12.1 Research Methodology
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Market Estimation Model
12.4 Disclaimer
no record found